Clinical Trial

Sucrose as a Standard in Cesarean Section Surgical Wound Healing to Reduce Hospital Time

Study acronym: SAGRA
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 23, 2024 (before its estimated September 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
It is a randomized, single-blind clinical trial, whose population to be studied will be randomized patients with a diagnosis of dehiscence and infection of a cesarean surgical wound who meet the inclusion and exclusion criteria. H0: Sucrose does not reduce hospital days in patients with surgical wound dehiscence. HA: Sucrose reduces hospital days in patients with surgical wound dehiscence.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-25.
Status change: Recruiting → Active, Not Recruiting 2024-08-22
Trial Details
NCT Number NCT06477770
Lead Sponsor Universidad Nacional Autonoma de Honduras
Conditions Surgical Wound Infection, Cesarean Wound; Dehiscence
Enrollment 24 participants
Start Date 2024-06-01
Primary Completion 2024-09-30 (estimated)
Study Completion 2024-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-23